Adient (ADNT) Q4 2024 earnings summary

Executive summary

• Achieved margin expansion in Q4 FY24 with adjusted EBITDA margin at 6.6%, up 30bps year-over-year, despite a 4% revenue decline to $3.6B.

• Fiscal 2024 finished slightly ahead of revised guidance, with strong free cash flow of $277M and disciplined capital allocation.

• Operational execution and business performance offset significant industry volume headwinds, with $70M in incremental positive business performance mitigating ~$200M in lower volumes.

• Continued focus on EMEA restructuring, APAC/China growth, and automation to drive future performance.

• Strategic transformation in China, including divestiture of non-core assets and new business wins with domestic OEMs, supports APAC growth.

Financial highlights

• Q4 FY24 revenue was $3.6B, down 4% year-over-year; full-year revenue was $14.7B, down 5%.

• Q4 adjusted EBITDA was $235M, flat year-over-year, with a 30bps margin expansion to 6.6%.

• Full-year adjusted EBITDA was $880M, down 6% year-over-year; margin at 6.0%.

• Adjusted net income for Q4 was $59M ($0.68/share); full-year adjusted net income was $166M ($1.84/share).

• Free cash flow for FY24 was $277M; $275M returned to shareholders via buybacks, repurchasing ~10% of shares outstanding.

Outlook and guidance

• FY25 consolidated sales expected at $14.1B–$14.4B, down ~3% FX-adjusted, reflecting lower production volumes.

• Adjusted EBITDA guidance for FY25 is $850M–$900M, with margins expected to be flat to slightly up.

• Free cash flow forecast at ~$200M, down year-over-year due to higher restructuring, capex, and cash taxes.

• Q1 2025 anticipated as the low point for sales and earnings; second half weighted for cash flow.

• Equity income expected at ~$80M, slightly lower due to JV changes; capex at ~$285M; interest expense at ~$185M.